08/28/2026
This commentary examines the regulatory, clinical, and ethical aspects of pharmaceutical drug compounding misuse in the United States (US), with a focus on dermatologic practice and associated patient safety risks. Learn more: https://bit.ly/4x0jbNG
by: Marc Brown, PhD, and Stefan Weiss, MD, FAAD